Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
8 papers
Recent·Most cited
Z. Li, Georgios Theocharidis, S. Lee, N. Kalavros, S. U. Nagalakshmi, M. Contreras, E.-A. Valsami, H. Nam, M. Guan, G. Chu, I. Mezghani, E. Wang, B. J. Sumpio, J. Hou, M. Gennari-Felipe, , A. Veves
The paper identifies a CHRM1-IL-17 neuroimmune axis that promotes diabetic wound healing through cholinergic modulation and local AChE inhibition.
bioRxiv · Nov 9, 2026 · PreprintImmunology
A. J. Najibi, R. S. Lane, M. C. Sobral, B. R. Freedman, J. G. Estupinan, A. Elosegui-Artola, C. M. Tringides, M. O. Dellacherie, K. Williams, S. Müller, S. J. Turley, D. J. Mooney
This study shows that lymph node expansion correlates with vaccine efficacy and immunization outcomes, with strong vaccines causing greater and longer-lasting LN expansion.
bioRxiv · Oct 25, 2022 · PreprintImmunology
K. Adu-Berchie, J. M. Brockman, Y. Liu, D. K. Y. Zhang, A. J. Najibi, A. Stafford, M. C. Sobral, Y. Binenbaum, M. O. Dellacherie, D. J. Mooney
This paper presents a biomaterial platform that enhances adoptive T cell therapy by engaging the host immune system, leading to better tumor control and long-term protection against solid tumors.
bioRxiv · Sep 10, 2022 · PreprintImmunology
G. Berger, E. H. Knelson, J. L. Jimenez-Macias, M. O. Nowicki, S. Han, P. H. Lizotte, K. Adu-Berchie, A. Stafford, N. Dimitrikakis, E. A. Chiocca, D. J. Mooney, D. A. Barbie, S. E. Lawler
This study shows that STING activation in glioblastoma models enhances immune responses and NK cell-mediated tumor regression, with long-term survival benefits in murine models.
bioRxiv · Feb 28, 2022 · PreprintCancer Biology
Y. Zhang, A. Mao, D. J. Mooney, D. A. Weitz
The paper describes a microfluidic method to create cell-laden alginate microgels with tunable compositions by adjusting cross-linker concentration.
bioRxiv · Jan 9, 2022 · PreprintBioengineering
F. Langellotto, B. T. Seiler, J. Yu, M. J. Cartwright, D. White, C. Yeager, M. Super, E. J. Doherty, D. H. Barouch, D. J. Mooney
This study develops a biomaterial vaccine using mesoporous silica rods to deliver SARS-CoV-2 antigens and adjuvants, showing rapid antibody responses and neutralizing activity.
bioRxiv · Jul 7, 2020 · PreprintImmunology
M. O. Dellacherie, A. Li, B. Y. Lu, C. S. Verbeke, L. Gu, A. Stafford, E. J. Doherty, D. J. Mooney
This study demonstrates that a single injection of mesoporous silica rods (MSRs) vaccine can generate potent and durable humoral immunity against small antigens like GnRH and Her2/neu peptides.
bioRxiv · Mar 17, 2020Bioengineering
M. Super, E. J. Doherty, M. J. Cartwright, B. T. Seiler, D. A. White, F. Langellotto, A. G. Stafford, N. Dimitrakakis, M. Karkada, A. R. Graveline, C. L. Horgan, K. R. Lightbown, F. R. Urena, C. D. Yeager, S. A. Rifai, , D. J. Mooney
The paper introduces a modular vaccine technology (ciVAX) that protects against multiple pathogens and septic shock by using inactivated bacteria and biomaterial scaffolds.
bioRxiv · Feb 25, 2020 · PreprintImmunology